SCHEMBL28025045

SCHEMBL28025045

C=CCC=CB(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL571281 0.71
SCHEMBL571282 0.71
SCHEMBL1003883 0.69
SCHEMBL1003884 0.69
SCHEMBL15124992 0.69 CA1 (0.30)
SCHEMBL6977352 0.65
SCHEMBL19736143 0.63 TSHR (0.31)
SCHEMBL28188329 0.63 TSHR (0.31)
SCHEMBL4194769 0.63
SCHEMBL2469835 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104854087-B Indole carboxamide derivatives as P2X receptor antagonists 埃科特莱茵药品有限公司 2017-03-22 CN disclosed
CN-104812749-B Indolecarboxamide derivant as P2X7 receptor antagonist 埃科特莱茵药品有限公司 2016-12-14 CN disclosed
CN-104854087-A As P2X7Indole carboxamide derivatives of receptor antagonists ACTELION PHARMACEUTICALS LTD 2015-08-19 CN disclosed
CN-104812749-A Iindole carboxamide derivatives as p2x7 receptor antagonists ACTELION PHARMACEUTICALS LTD 2015-07-29 CN disclosed